News

Nexalin’s method aims to treat substance use disorders by stimulating neural pathways linked to addiction and withdrawal ...
Electrical stimulation in psychiatry is still in its infancy. Yet the increasing precision of brain imaging and stimulation ...
Deep Brain Stimulation therapy is designed to change how brain cells work by giving electrical stimulation to areas of the ...
A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...
Precision meets noninvasive treatment in the revolutionary approach known as focused ultrasound (FUS). Focused ultrasound is a new noninvasive therapeutic approach for people with either Parkinson’s ...
Northwell Health is conducting a clinical trial to address treatment-resistant depression using deep brain stimulation.
Pulsing about 130 times a second, the deep brain stimulation (DBS) device, a kind of pacemaker, energizes an area that scientists say is key in regulating moods. Ellis, 49, a regulatory compliance ...
NIMS Hyderabad offers advanced Parkinson's disease treatment with DBS surgery, improving patient outcomes and quality of life ...
This milestone further strengthens Nexalin’s intellectual property portfolio and affirms the potential of its proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology, a non-invasive and ...
Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...
Nexalin Technology receives US patent for Deep Intracranial Frequency Stimulation technology in treating substance use disorders: Houston, Texas Wednesday, April 16, 2025, 17:00 H ...